NR3C1 and prostate cancer: GR expression was reduced in prostatic cancer cells to lower levels than in epithelium of BPH [121] while GR expression was increased in malignant-transformed prostate epithelial RWPE-2 cells [7], indicating controversies on GR expression in prostate cancer.